NVCR — NovoCure Limited price, chart and key statistics

Price data

Price

$15.71

YTD price return

+21.50%

YTD total return

+21.50%

Next earnings

Oct 29, 2026 · Before open

Market cap

1.8B2016-12 681.2M2026-10 1.8B+168.5% over the window

Enterprise value

2B

Shares outstanding

116.4M2016-06 85.8M2026-06 116.4M+35.8% over the window

52W low

$9.82

52W high

$21.45

From 52W high

-26.76%

From 52W low

+59.98%

52W range

51%

Volume

Rel volume

1.25×

30D volume

1.4M

30D $ vol

21.3M

Fundamentals

Sales (ttm)

699.2M2016-06 52.3M2026-06 699.2M+1236.7% over the window

Sales/share

$6.002016-06 $0.612026-06 $6.00+884.6% over the window

EPS (ttm)

-$1.312018-09 -$0.632026-06 -$1.31+106.5% over the window

FCF (ttm)

-25.4M2016-06 -114.2M2026-06 -25.4M-77.7% over the window

FCF/share

-$0.222016-06 -$1.332026-06 -$0.22-83.6% over the window

Book value/share

$2.902016-06 $2.182026-06 $2.90+33.4% over the window

Net margin

-21.25%2016-06 -258.1%2026-06 -21.2%-91.8% over the window

ROE

-43.94%2016-06 -72.3%2026-06 -43.9%-39.2% over the window

ROA

-18.68%2016-06 -53.9%2026-06 -18.7%-65.3% over the window

Debt / equity

0.58×2015-12 0.092025-12 0.57+522.1% over the window

Current ratio

2.892016-06 6.782026-06 2.89-57.3% over the window

Growth (CAGR, ttm) · 10Y

Sales

+10.96%2025-06-30 → 2026-06-30630.2M → 699.2M (+11.0% total)+11.26%2023-06-30 → 2026-06-30507.7M → 699.2M (+37.7% total)+5.12%2021-06-30 → 2026-06-30544.8M → 699.2M (+28.3% total)+29.60%2016-06-30 → 2026-06-3052.3M → 699.2M (+1236.7% total)

Shares

+4.16%2025-06-30 → 2026-06-30111.8M → 116.4M (+4.2% total)+2.98%2023-06-30 → 2026-06-30106.6M → 116.4M (+9.2% total)+2.36%2021-06-30 → 2026-06-30103.6M → 116.4M (+12.3% total)+3.10%2016-06-30 → 2026-06-3085.8M → 116.4M (+35.8% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+6.53%2025-06-30 → 2026-06-30$5.64 → $6.00 (+6.5% total)+8.04%2023-06-30 → 2026-06-30$4.76 → $6.00 (+26.1% total)+2.70%2021-06-30 → 2026-06-30$5.26 → $6.00 (+14.2% total)+25.70%2016-06-30 → 2026-06-30$0.61 → $6.00 (+884.6% total)

Book value/share

-7.11%2025-06-30 → 2026-06-30$3.13 → $2.90 (-7.1% total)-9.36%2023-06-30 → 2026-06-30$3.90 → $2.90 (-25.5% total)-5.40%2021-06-30 → 2026-06-30$3.83 → $2.90 (-24.2% total)+2.93%2016-06-30 → 2026-06-30$2.18 → $2.90 (+33.4% total)

Price

+8.50%2025-10-20 → 2026-10-20$14.48 → $15.71 (+8.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.57%2023-10-20 → 2026-10-20$14.56 → $15.71 (+7.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-33.19%2021-10-20 → 2026-10-20$117.95 → $15.71 (-86.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.54%2016-10-19 → 2026-10-20$6.92 → $15.71 (+127.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+8.50%2025-10-20 → 2026-10-20$14.48 → $15.71 (+8.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+2.57%2023-10-20 → 2026-10-20$14.56 → $15.71 (+7.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-33.19%2021-10-20 → 2026-10-20$117.95 → $15.71 (-86.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+8.54%2016-10-19 → 2026-10-20$6.92 → $15.71 (+127.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-12.0×2016-12 -4.782026-10 -12.31+157.8% over the window

Fwd P/E

-18.5×

P/S (ttm)Market cap ÷ TTM revenue.

2.6×2016-12 10.482026-10 2.62-75.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

5.4×2016-12 4.302026-10 5.41+25.7% over the window

EV/Sales (ttm)

2.8×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-1.39%2016-09 -18.5%2026-06 -1.4%-92.2% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 116.4M ÷ 111.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-4.16%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-4.16%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-4.16%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-3.6M) ÷ today's market cap ($1.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-0.20%2016-09 -23.1%2026-06 -0.2%-99.1% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-3.6M + TTM dividends $0) ÷ today's market cap ($1.8B). Same caveat as the cash buyback yield.

-0.20%2016-09 -23.1%2026-06 -0.2%-99.1% over the window

Vs own 10Y history

P/S

10th

P/B

25th

P/FCF

88th